Overall colorectal cancer screening rates in the U.S. have increased in recent years but continue to lag behind goal levels, a cover story in the January ACP Internist reported.
After surgery for stage II or III colorectal cancer, more vs less frequent follow-up did not differ for 5-year mortality | ACP Gastroenterology Monthly
The findings help clarify the ideal process for surveillance of clinical recurrence of colorectal cancer, an ACP Journal Club commentary said.
Higher circulating vitamin D level associated with lower colorectal cancer risk | ACP Gastroenterology Monthly
Participants who had circulating vitamin D levels under 30 nmol/L had a 31% higher risk of colorectal cancer compared to those with levels between 50 and 62.5 nmol/L.
Rates of cancer detection and the number of positive test results per cancer case detected varied significantly by age and sex, which suggests that modifying positivity thresholds by subgroups might optimize screening program performance.
Single sigmoidoscopy screening may reduce colorectal cancer, mortality in men but not women | ACP Gastroenterology Monthly
Patients in Norway were randomly assigned to flexible sigmoidoscopy with and without additional fecal blood testing (with colonoscopy offered if results were positive) and were compared to patients offered no screening.
Adults should be screened with either a high-sensitivity stool-based test or a structural (visual) examination, depending on patient preference and test availability, the guideline said.
Earlier colorectal cancer screening recommended for patients with cystic fibrosis | ACP Gastroenterology Monthly
The Cystic Fibrosis Colorectal Cancer Screening Task Force based its recommendations on a review of the literature and a modeling study of screening strategies for colorectal cancer that estimated the costs and benefits of screening in patients with
Studies this month looked at colorectal cancer screening, risk associated with dietary patterns, and estimated U.S. incidence.
FIT may be useful for screening above-average-risk populations for colorectal cancer | ACP Gastroenterology Monthly
A meta-analysis of 12 studies found that fecal immunochemical testing (FIT) may be a viable alternative screening strategy for patients at increased risk for colorectal cancer, but the authors and an accompanying editorial noted that the quality of
One recent study looked at screening based on age and family history, while another looked at the effectiveness of fecal immunochemical testing with and without postpolypectomy surveillance colonoscopy.